Biomark Diagnostics

Biomark Diagnostics

An oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. Learn more

Launch date
Employees
Market cap
€15.1m
Enterprise valuation
€16m (Public information from Sep 2024)
Richmond British Columbia (HQ)
Authorizing premium user...